February 2, 2021
McKesson Reports Fiscal 2021 Third-Quarter Results
Third-Quarter Highlights, Year-over-Year: Total revenues of $62.6 billion, reflecting 6% growth. McKesson recorded a pre-tax charge of $8.1 billion related…
Pharmaceuticals, Biotechnology and Life Sciences
Third-Quarter Highlights, Year-over-Year: Total revenues of $62.6 billion, reflecting 6% growth. McKesson recorded a pre-tax charge of $8.1 billion related…
– Ono to make upfront payment of approximately $16.3 million to Ribon in addition to other potential milestone payments of…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
Superiority of deucravacitinib was demonstrated on both co-primary endpoints and multiple key secondary endpoints in the POETYK PSO-2 trial The…
NEW YORK & SHANGHAI–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) and WuXi STA – a subsidiary of WuXi AppTec – today…
-Company Expects It Will Have 180 Days of Exclusivity- WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the…
Fourth Quarter 2020 Highlights Sales of $787 million grew 10% as reported and 7% in constant currency GAAP EPS of…
Fourth Quarter 2020 Highlights Sales of $787 million grew 10% as reported and 7% in constant currency GAAP EPS of…
Fourth Quarter 2020 Highlights Sales of $787 million grew 10% as reported and 7% in constant currency GAAP EPS of…
Upjohn Business(1) Now Accounted for as a Discontinued Operation for All Periods Presented, Excluded from Adjusted(2) Results Full-Year 2020 Revenues…